Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403111
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-27
Brief Title:
FMTImmunotherapyChemotherapy as First-line Treatment for Driver-gene Negative Advanced NSCLC
Sponsor:
Changzhou No2 Peoples Hospital
Organization:
Changzhou No2 Peoples Hospital
Organization Data
Organization:
Changzhou No2 Peoples Hospital
Class:
OTHER
Study ID:
2024YLJSA005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Changzhou No2 Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Hua Jiang
Responsible Party Title:
Chief Director of Oncology Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Changzhou No2 Peoples Hospital
Old Name:
None
Old Organization:
None